Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations

OBJECTIVE: To evaluate the benefit–risk profile (BRP) of oxycodone/naloxone (OXN) and tapentadol (TAP) in patients with chronic low back pain (cLBP) with a neuropathic component (NC) in routine clinical practice. METHODS: This was a blinded end point analysis of randomly selected 12-week routine/ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueberall, Michael A, Mueller-Schwefe, Gerhard H H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115682/
https://www.ncbi.nlm.nih.gov/pubmed/27881925
http://dx.doi.org/10.2147/JPR.S112418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115682/
https://www.ncbi.nlm.nih.gov/pubmed/27881925
http://dx.doi.org/10.2147/JPR.S112418

Ejemplares similares